Trials / Completed
CompletedNCT02951624
The Effect of Frequency and Duration of Breaks in Sitting Time on Metabolic Cardiovascular Risk Factors
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Rigshospitalet, Denmark · Academic / Other
- Sex
- Male
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The primary aim of this study is to investigate the acute effect of the frequency and duration of breaks in sitting time on the metabolic risk factor profile.
Detailed description
Fifteen (n=15) sedentary adult overweight males will be included in the study. All participants will undergo the four interventions in a randomized cross-over design. Wash out between intervention will be minimum four days. Control (CON): Participants will be sedentary. Sedentary time will be spent sitting in a chair, restricted to sedentary behaviors (working on a computer, reading, watching TV, etc.), with a target MET below 1.5 (i.e. 1.5 times REE). Participants will only be allowed to stand or walk to go to the toilet. Breaker: Participants will be breaking up prolonged sitting with 2 min intervals of low intensity walking. Intermediate: Participants will be breaking up prolonged sitting with 6 min intervals of low intensity walking Prolonger: Participants will be breaking up prolonged sitting with 12 min intervals of low intensity walking All interventions will be matched for total physical activity as well as sitting. Thus, we aim for the active interventions to be iso-caloric.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Control | Control intervention |
| BEHAVIORAL | Breaker | Short breaks of physical activity |
| BEHAVIORAL | Prolonger | longer breaks of physical activity |
| BEHAVIORAL | Intermediate | Intermediate breaks of physical activity |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2018-07-15
- Completion
- 2018-07-15
- First posted
- 2016-11-01
- Last updated
- 2018-12-14
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02951624. Inclusion in this directory is not an endorsement.